Drug Price Trends for ANTACID EX-STR TABLET CHEW

Average Pharmacy Cost for ANTACID EX-STR TABLET CHEW

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04338	EACH	2025-01-22
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04390	EACH	2024-12-18
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04355	EACH	2024-11-20
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04528	EACH	2024-10-23
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04383	EACH	2024-09-18
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04249	EACH	2024-08-21
ANTACID EX-STR TABLET CHEW	70000-0234-01	0.04381	EACH	2024-07-17

Antacids Market Analysis and Price Projections for Antacid Extra Strength Tablets

Market Overview

The antacids market is experiencing significant growth, driven by the increasing prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions. Here are some key points to consider:

• Market Size and Growth: The global antacids market was valued at $6.7 billion in 2022 and is projected to reach $9.1 billion by 2032, growing at a CAGR of 3.1% from 2023 to 2032[1][3].

Segmentation by Formulation Type

Tablets Segment

The tablets segment, particularly chewable antacid tablets, dominates the market due to their convenience, wide availability, and variety of flavors and formulations.

• Popularity and Convenience: Antacid tablets are a popular choice among consumers because they are easy to use and store. The development and launch of chewable antacid tablets have further boosted their popularity[1][3].
• Market Growth: The tablet segment is expected to continue growing, driven by the presence of various chewable antacid tablets with different flavors, which improve patient adherence to the medication[3].

Liquid Segment

While tablets dominate, the liquid segment is anticipated to grow at the fastest rate during the forecast period.

• Ease of Use: Liquid antacids are gaining popularity due to their ease of use and convenience, making them suitable for on-the-go consumption. They are also preferred by children and elderly patients who may have difficulty swallowing tablets or capsules[1].

Segmentation by Distribution Channel

Drug Store & Retail Pharmacies

The drug store and retail pharmacies segment dominates the market in terms of revenue.

• Convenience and Accessibility: Consumers prefer purchasing antacids over the counter from these channels for occasional heartburn or indigestion, rather than seeking prescription medications or medical intervention[1].

Regional Analysis

North America

North America holds a significant share of the antacids market and is expected to maintain its dominance during the forecast period.

• Healthcare Infrastructure and Prevalence of Gastrointestinal Disorders: The region's well-developed healthcare infrastructure, high prevalence of gastrointestinal diseases such as GERD and peptic ulcer disease, and easy availability of over-the-counter medications contribute to its market share[1][3].

Asia-Pacific

The Asia-Pacific region is anticipated to witness notable growth due to the surge in demand for antacids and the unmet medical needs of the large population in this region.

• Growing Demand and Unmet Needs: The increasing incidence of gastrointestinal disorders and the growing geriatric population in this region are driving the demand for antacids[1][3].

Key Market Players and Product Innovations

Major players in the market, such as Bayer AG, Reckitt Benckiser Group PLC, Cipla Ltd, and Pfizer Inc., are focusing on the development of new antacids that are easily accessible and cost-effective.

• Product Approvals and Innovations: Recent product approvals, such as glycopyrrolate orally disintegrating tablets and generic Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, are contributing to market growth[3].

Price Projections and Market Trends

Price Factors

The prices of antacid extra strength tablets are influenced by several factors, including the formulation type, distribution channel, and regional market dynamics.

• Competition and Innovation: The market is competitive, with many players offering a range of products. This competition, along with innovations in formulation and delivery, can impact pricing strategies[1][3].

Consumer Preferences

Consumer preferences for convenient and palatable products are driving the market towards chewable tablets and liquid antacids.

• Flavor Varieties and Ease of Use: Products like Equate Extra Strength Smooth Chews Antacid Tablets and Walgreens Extra Strength Antacid Chewable Tablets, which offer assorted fruit flavors and ease of use, are gaining traction[4][5].

Impact of Lifestyle Changes

Lifestyle changes, including smoking, changes in sleeping patterns, and unhealthy eating habits, are significant factors contributing to the rise in gastrointestinal disorders and, consequently, the demand for antacids.

• Self-Medication Trend: The trend towards self-medication, particularly in North America, is increasing the demand for over-the-counter digestive products like antacids[1][3].

Geriatric Population

The growing geriatric population is another key driver of the antacids market.

• Increased Prevalence of Gastrointestinal Disorders: The elderly population is more prone to gastrointestinal disorders, which is expected to fuel the demand for antacids and indigestion medicines[3].

Key Takeaways

• The antacids market is projected to grow significantly, driven by the increasing prevalence of gastrointestinal disorders and lifestyle changes.
• The tablets segment, particularly chewable antacid tablets, dominates the market due to convenience and variety.
• North America holds a significant market share due to well-developed healthcare infrastructure and high prevalence of gastrointestinal diseases.
• The Asia-Pacific region is expected to witness notable growth due to unmet medical needs and a growing geriatric population.
• Major players are focusing on developing new, easily accessible, and cost-effective antacids.

Frequently Asked Questions

1. What is the projected market size of the antacids market by 2032?

The antacids market is projected to reach $9.1 billion by 2032, growing at a CAGR of 3.1% from 2023 to 2032[1].

2. Which formulation type is expected to grow the fastest in the antacids market?

The liquid segment is anticipated to grow at the fastest rate during the forecast period due to its ease of use and convenience[1].

3. What are the key factors driving the growth of the antacids market in North America?

The growth in North America is attributed to the availability of well-developed healthcare infrastructure, high prevalence of gastrointestinal diseases, and easy availability of over-the-counter medications[1][3].

4. How does the growing geriatric population impact the antacids market?

The growing geriatric population is expected to drive market growth as the elderly are more prone to gastrointestinal disorders, increasing the demand for antacids and indigestion medicines[3].

5. What are some recent product innovations in the antacids market?

Recent innovations include the approval of glycopyrrolate orally disintegrating tablets and the introduction of generic Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules[3].

Sources:

1. Allied Market Research - Antacids Market Size & Share | Statistics Report [2023-2032]
2. CVS - Gaviscon Extra Strength Antacid Chewable Tablets, 100 CT
3. Mordor Intelligence - Antacids Market Report | Industry Analysis, Size & Forecast Overview
4. Kroger - Extra Strength Smooth Chews Antacid Tablets; Assorted Fruit
5. Walgreens - Walgreens Extra Strength Antacid Chewable Tablets, 750 mg